Drug and device makers could end up paying upwards of $200,000 in the first year the federal Sunshine Act is in force -- not including legal fees and information technology upgrades, lawyer Sheva Sanders said at a LifeScience Alley conference. Seven states and the District of Columbia have laws regarding disclosure of financial relationships between manufacturers and health care providers, with varying fees and requirements.

Full Story:

Related Summaries